Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 79

Sort by

Sort Order Select

Journal Articles

Encouraging Outcomes of Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Patients with Acute Lymphoblastic Leukemia in Second Complete Remission

Kohei Higuchi, MD, Maho Sato, MD PhD, Osamu Kondo, MD, Aya Ioi, MD, Azusa Mayumi, MD, Mariko Shimizu, MD, Akihisa Sawada, MD PhD, Masahiro Yasui, MD, Masami Inoue, MD

Blood (2014) 124 (21): 5933.

https://doi.org/10.1182/blood.V124.21.5933.5933

Published: 2014

Journal Articles

Imatinib Combined with Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Versus Imatinib Alone for Young Patients with Chronic Myeloid Leukemia in Chronic Phase

Yanmin Zhao, Yi Luo, Yamin Tan, Jimin Shi, Zhen Cai, MDPhD, Maofang Lin, He Huang, MDPhD

Blood (2014) 124 (21): 4568.

https://doi.org/10.1182/blood.V124.21.4568.4568

Published: 2014

Journal Articles

The Curative Potential Of Fludarabine125, Melphalan100, and Busulfan4 As a Conditioning Regimen For Myeloid Malignancies Of Elderly Patients

Tomoaki Ueda, MD, Aki Sato, M.D., Kazuya Sakai, MD, Hiroyuki Muranushi, MD, Yusuke Okamoto, MD, Taku Tsukamoto, MD, Hiroyuki Sugiura, MD, Hiroyuki Matsui, MD, Tomoyasu Jo, MD, Kazuya Okada, MD, Takeshi Maeda, MD, Tatsuhito Onishi, MD, Akane Kunitomi, MD, PhD, Yasunori Ueda, MD, PhD

Blood (2013) 122 (21): 4551.

https://doi.org/10.1182/blood.V122.21.4551.4551

Published: 2013

Journal Articles

Expression of SOCS1 and SOCS3 Genes with Human Cytomegalovirus Infection After Allogeneic Hematopoietic Stem Cell Transplantation.

Tae Hyang Lee, Ji Yoon Lee, Sohye Park, Jae-Ho Yoon, Seung Hwan Shin, Byung-Sik Cho, MD, PhD, Dong-Gun Lee, Woo-Sung Min, MD, PhD, Heeje Kim

Blood (2012) 120 (21): 3038.

https://doi.org/10.1182/blood.V120.21.3038.3038

Published: 2012

Journal Articles

Does the Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) Predict Transplant Outcomes?: A Prospective Multicenter Validation Study of the Kanto Study Group for Cell Therapy (KSGCT)

Aya Nakaya, MD, PhD, Takehiko Mori, MD, PhD, Masatsugu Tanaka, MD, Naoto Tomita, MD, Chiaki Nakaseko, MD, PhD, Shingo Yano, MD, Shin Fujisawa, MD, Hisashi Sakamaki, MD, Nobuyuki Aotsuka, MD, PhD, Akira Yokota, MD, Yoshinobu Kanda, MD, PhD, Toru Sakura, MD, PhD, Yasuhito Nannya, MD, PhD, Takayuki Saitoh, MD, PhD, Heiwa Kanamori, MD, PhD, Satoshi Takahashi, MD, PhD, Shinichiro Okamoto, MD, PhD

Blood (2012) 120 (21): 1993.

https://doi.org/10.1182/blood.V120.21.1993.1993

Published: 2012

Journal Articles

Outcome and Prognostic Index for Reduced-Intensity Allogeneic Stem Cell Transplantation (RIST) for Elderly Patients with De Novo Acute Myeloid Leukemia (AML): A Study From the AML Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Heiwa Kanamori, MD, PhD, Takahiro Fukuda, MD, PhD, Shuichi Taniguchi, MD, PhD, Masashi Sawa, MD, PhD, Tadakazu Kondo, MD, PhD, Koichi Miyamura, MD, PhD, Naoki Kobayashi, MD, PhD, Hikaru Kobayashi, MD, PhD, Yasuo Morishima, MD, PhD, Makoto Hirokawa, MD, PhD, Yoshiko Atsuta, MD, PhD, Akiyoshi Takami, MD, PhD

Blood (2012) 120 (21): 1918.

https://doi.org/10.1182/blood.V120.21.1918.1918

Published: 2012

Journal Articles

ACE Polymorphism and Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation

Makoto Onizuka, MD, PhD, Mitsuki Miyamono, M.D., Shinichiro Machida, M.D., Toyosaki Masako, M.D. Ph.D, Yoshiaki Ogawa, M.D. Ph.D, Hiroshi Kawada, MD, PhD, Kiyoshi Ando, MD, PhD

Blood (2012) 120 (21): 1943.

https://doi.org/10.1182/blood.V120.21.1943.1943

Published: 2012

Journal Articles

Outcomes of Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia with t(4;11)

Yuko Sekiya, MD, Atsushi Narita, MD, Nao Yoshida, MD, PhD, Kimikazu Matsumoto, MD, PhD, Koji Kato, MD, PhD

Blood (2011) 118 (21): 4502.

https://doi.org/10.1182/blood.V118.21.4502.4502

Published: 2011

Journal Articles

Early Deaths After Allogeneic Stem Cell Transplantation in Adult T Cell Leukemia/Lymphoma (ATLL) Patients - A Single Institute Retrospective Analysis

Shogo Takeuchi, MD, Nobuaki Nakano, MD, Ayumu Kubota, MD, Yoshifusa Takatsuka, MD, Mayumi Tokunaga, MD, Takahiro Itoyama, MD, Atae Utsunomiya, MD, PhD, Kentarou Yonekura, MD

Blood (2011) 118 (21): 4503.

https://doi.org/10.1182/blood.V118.21.4503.4503

Published: 2011

Journal Articles

Favorable Outcome of Reduced-Intensity Stem Cell Transplantation for Adult T-Cell Leukemia

Fumie Iwai, Hitomi Kaneko, MD, PhD, Goichi Tatsumi, Tadahiko Matsumoto, Shinya Inada, Yuki Sueki, Nao Toyooka, Sumie Fujii, Chisiho Nakamura, Mitsumasa Watanabe, MD, PhD, Hirokazu Hirata, MD, PhD, Yasuo Miura, MD, PhD, Mitsuru Tsudo, MD, PhD

Blood (2011) 118 (21): 4480.

https://doi.org/10.1182/blood.V118.21.4480.4480

Published: 2011

Journal Articles

Fludarabine-Based Reduced Intensity Hematopoietic Stem Cell Transplantation (RIST) for Patients Aged 50–70 Years with Acute Lymphoblastic Leukemia (ALL) in Remission: A Study From the ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Heiwa Kanamori, MD, Shinichi Kako, MD, Harumi Kato, MD, Satoshi Nishiwaki, MD, Tatsuo Furukawa, MD, Mari Saito, MS, Shuichi Taniguchi, MD, PhD, Hirohisa Nakamae, MD, PhD, Toshiaki Yujiri, MD, Tokiko Naganuma-Inoue, MD, Yasuo Morishima, MD, PhD, Ritsuro Suzuki, MD, PhD, Hisashi Sakamaki, MD, Junji Tanaka, MD

Blood (2011) 118 (21): 1935.

https://doi.org/10.1182/blood.V118.21.1935.1935

Published: 2011

Journal Articles

Mechanism of Marked Reduction In the Severity of Graft-Versus-Host Disease by Reduced-Intensity Conditioning In Murine MHC-Haploidentical BMT Model

Takayuki Inoue, Kazuhiro Ikegame, Satoshi Yoshihara, Katsuji Kaida, Kyoko Taniguchi, Hiroya Tamaki, Tatsuya Fujioka, Masaya Okada, Ruri Kato, Yoko Yamamoto, Toshihiro Soma, Hiroyasu Ogawa

Blood (2010) 116 (21): 4707.

https://doi.org/10.1182/blood.V116.21.4707.4707

Published: 2010

Journal Articles

Use of Targeted Lymphocyte Depletion as a Personalized Approach to Improve Engraftment and Disease Control Following Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Using HLA-Matched Unrelated Donors

Rachel B. Salit, MD, Steven Z. Pavletic, MD, Daniel H. Fowler, MD, Jennifer Wilder, RN, Kelly Bryant, RN, Seth M. Steinberg, PhD, Frances T. Hakim, PhD, Michael R. Bishop, MD

Blood (2010) 116 (21): 3530.

https://doi.org/10.1182/blood.V116.21.3530.3530

Published: 2010

Journal Articles

Successful Reduced-Intensity Stem Cell Transplantation From Unrelated Cord Blood In Three Patients with X-Linked Severe Combined Immunodeficiency.

Akihiro Iguchi, MD, PhD, Mizuho Ichikawa, MD, PhD, Nobuaki Kawamura, MD, PhD, Shunichiro Takezaki, MD, Yuka Okura, MD, Jun Inamoto, MD, Junjiro Ohshima, MD, PhD, Tomonobu Sato, MD, PhD, Masahide Nakajima, MD, PhD, Makoto Kaneda, MD, Yuko Cho, MD, PhD, Masafumi Yamada, MD, PhD, Ryoji Kobayashi, MD, PhD, Ichiro Kobayashi, MD, PhD, Tadashi Ariga, MD, PhD

Blood (2010) 116 (21): 4571.

https://doi.org/10.1182/blood.V116.21.4571.4571

Published: 2010

Journal Articles

The Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) and Survival After Extracorporeal Photopheresis, Pentostatin, and Reduced Dose Total Body Irradiation (TUFTs) Conditioning Prior to Allogeneic Stem Cell Transplantation (SCT)

Shahrukh Hashmi, MD, MPH, Jamie L Oliva, MS, NP, Jane L. Liesveld, MD, Gordon L. Phillips, II, MD, Diane Nichols, Michael Becker, MD

Blood (2010) 116 (21): 1337.

https://doi.org/10.1182/blood.V116.21.1337.1337

Published: 2010

Journal Articles

Engraftment Syndrome (ES) After Reduced-Intensity Stem Cell Transplantation (RIST): ES May Have a Negative Impact on Survival In Standard-Risk Patients

Takeshi Maeda, MD, Kimikazu Yakushijin, MD, Yoshitaka Asakura, MD, Nobuhiro Hiramoto, MD, Saiko Kurosawa, MD, Yutaro Kamiyama, MD, Suguru Fukuhara, MD, Niina Ueno, MD, Sung-Won Kim, MD, Shin-Ichiro Mori, MD, Ryuji Tanosaki, MD, Yuji Heike, MD, Kensei Tobinai, MD, Yoichi Takaue, MD, Takahiro Fukuda, MD

Blood (2010) 116 (21): 2318.

https://doi.org/10.1182/blood.V116.21.2318.2318

Published: 2010

Journal Articles

Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome with a Reduced Intensity Conditioning Regimen Consisting of Intravenous Busulfan, Fludarabine, and 400 Cgy Total Body Irradiation.

Sung Eun Lee, M.D, Yoo Jin Kim, MD, Seok Goo Cho, Byung Sik Cho, Ki-Seong Eom, Hee Je Kim, Seok Lee, Chang-Ki Min, MD, Dong Wook Kim, Jong Wook Lee, Woo Sung Min, Chong Won Park, Chun Choo Kim

Blood (2009) 114 (22): 4327.

https://doi.org/10.1182/blood.V114.22.4327.4327

Published: 2009

Journal Articles

GvATLL Effect in the Relapse and Progression Cases After Hematopoietic Stem Cell Transplantation (HSCT) for Adult T-Cell Leukemia/Lymphoma (ATLL).

Nobuaki Nakano, MD, Ayumu Kubota, MD, Mayumi Tokunaga, MD, Masahito Tokunaga, MD, Shogo Takeuchi, MD, Yosifusa Takatsuka, MD, Atae Utsunomiya, MD, PhD

Blood (2009) 114 (22): 4299.

https://doi.org/10.1182/blood.V114.22.4299.4299

Published: 2009

Journal Articles

Feasibility of Cyclosporine and Short-Term Methotrexate for Graft-Vs.-Host disease Prophylaxis in T-Cell-Replete, Reduced-Intensity Allogeneic Bone Marrow Transplantation From Unrelated Donors.

Takahiko Nakane, MD, PhD, Hirohisa Nakamae, MD, PhD, Hideo Koh, MD, Mika Nakamae, MD, PhD, Yoshiki Hayashi, MD, Mitsutaka Nishimoto, MD, Takuro Yoshimura, MD, Eri Inoue, MD, Atsushi Inoue, MD, Ran Aimoto, MD, Mizuki Aimoto, MD, Yoshiki Terada, MD, PhD, Ki-Ryang Koh, MD, PhD, Takahisa Yamane, MD, PhD, Masayuki Hino, MD, PhD

Blood (2009) 114 (22): 4347.

https://doi.org/10.1182/blood.V114.22.4347.4347

Published: 2009

Journal Articles

Targeted Lymphocyte Depletion: A Personalized Approach to Achieve Rapid Complete Donor Chimerism and Enhance Graft-Versus-Tumor Effects Following Reduced Intensity Allogeneic Stem Cell Transplantation for High-Risk Hematologic Malignancies.

Rachel B. Salit, MD, Seth Steinberg, PhD, Daniel H. Fowler, MD, Jeanne Odom, RN, Kelly Bryant, RN, Michael R. Bishop, MD

Blood (2009) 114 (22): 656.

https://doi.org/10.1182/blood.V114.22.656.656

Published: 2009

NARROW

Encouraging Outcomes of Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Patients with Acute Lymphoblastic Leukemia in Second Complete Remission

Imatinib Combined with Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Versus Imatinib Alone for Young Patients with Chronic Myeloid Leukemia in Chronic Phase

The Curative Potential Of Fludarabine125, Melphalan100, and Busulfan4 As a Conditioning Regimen For Myeloid Malignancies Of Elderly Patients

Expression of SOCS1 and SOCS3 Genes with Human Cytomegalovirus Infection After Allogeneic Hematopoietic Stem Cell Transplantation.

Does the Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) Predict Transplant Outcomes?: A Prospective Multicenter Validation Study of the Kanto Study Group for Cell Therapy (KSGCT)

Outcome and Prognostic Index for Reduced-Intensity Allogeneic Stem Cell Transplantation (RIST) for Elderly Patients with De Novo Acute Myeloid Leukemia (AML): A Study From the AML Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

ACE Polymorphism and Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation

Outcomes of Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia with t(4;11)

Early Deaths After Allogeneic Stem Cell Transplantation in Adult T Cell Leukemia/Lymphoma (ATLL) Patients - A Single Institute Retrospective Analysis

Favorable Outcome of Reduced-Intensity Stem Cell Transplantation for Adult T-Cell Leukemia

Fludarabine-Based Reduced Intensity Hematopoietic Stem Cell Transplantation (RIST) for Patients Aged 50–70 Years with Acute Lymphoblastic Leukemia (ALL) in Remission: A Study From the ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Mechanism of Marked Reduction In the Severity of Graft-Versus-Host Disease by Reduced-Intensity Conditioning In Murine MHC-Haploidentical BMT Model

Use of Targeted Lymphocyte Depletion as a Personalized Approach to Improve Engraftment and Disease Control Following Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Using HLA-Matched Unrelated Donors

Successful Reduced-Intensity Stem Cell Transplantation From Unrelated Cord Blood In Three Patients with X-Linked Severe Combined Immunodeficiency.

The Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) and Survival After Extracorporeal Photopheresis, Pentostatin, and Reduced Dose Total Body Irradiation (TUFTs) Conditioning Prior to Allogeneic Stem Cell Transplantation (SCT)

Engraftment Syndrome (ES) After Reduced-Intensity Stem Cell Transplantation (RIST): ES May Have a Negative Impact on Survival In Standard-Risk Patients

Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome with a Reduced Intensity Conditioning Regimen Consisting of Intravenous Busulfan, Fludarabine, and 400 Cgy Total Body Irradiation.

GvATLL Effect in the Relapse and Progression Cases After Hematopoietic Stem Cell Transplantation (HSCT) for Adult T-Cell Leukemia/Lymphoma (ATLL).

Feasibility of Cyclosporine and Short-Term Methotrexate for Graft-Vs.-Host disease Prophylaxis in T-Cell-Replete, Reduced-Intensity Allogeneic Bone Marrow Transplantation From Unrelated Donors.

Targeted Lymphocyte Depletion: A Personalized Approach to Achieve Rapid Complete Donor Chimerism and Enhance Graft-Versus-Tumor Effects Following Reduced Intensity Allogeneic Stem Cell Transplantation for High-Risk Hematologic Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only